Century Therapeutics (IPSC): SVP Finance & Operations sold

~$3.2K
Approx. value · 1,658 sh @ $1.93: 503K
Holds after · shares reported

Traded: Sep 14, 2026
Filed: Sep 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Aug 3, 2026InsiderOfficer sold ~$544 of IPSC shares in the open market
Aug 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
Sep 8, 2026Insider · 2 peopleInsiders: 2 sales (~$2K)
Sep 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 9, 2026, the Board of Directors (the “Board”) of Century Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from six to seven directors and appointed Mr. Joseph Truitt as a member of the Board, effective as of September 9, 2026 (the “Effective Date”).”
Sep 14, 2026 · this disclosureInsiderOfficer sold ~$3.2K of IPSC shares in the open market

What came next

Sep 14, 2026InsiderOfficer sold ~$5K of IPSC shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Century Therapeutics

For Century Therapeutics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IPSC page.

Other recent filings by Douglas Carr, SVP Finance & Operations

The full history of Douglas Carr, SVP Finance & Operations is on the profile page.

Other disclosures at Century Therapeutics

Everything OQRO holds on this company is on its IPSC page.

Century Therapeutics (IPSC)SVP Finance & Operations sold ~$3.2K